Price (delayed)
$7.78
Market cap
$905.41M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.02
Enterprise value
$873.21M
MiMedx is an industry leader in utilizing birth tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare.
There are no recent dividends present for MDXG.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.